Stephanie Sirota

Stephanie Sirota is a Partner and the Chief Business Officer at RTW Investments, a life sciences investment firm. In this capacity, she leads business development, strategic partnerships, and investor relations, and has played a pivotal role in growing the firm's assets from $27 million into a global biotechnology portfolio. She also serves as a director for RTW Biotech Opportunities Ltd, which is listed on the London Stock Exchange, president of the RTW Foundation, and co-chair of the Council of the New York Philharmonic. Previously, Sirota was a director at the macro and commodity investment manager Valhalla Capital Advisors and advised on mergers, acquisitions, and initial public offerings at Lehman Brothers. Holding degrees from Columbia University and the Columbia Graduate School of Journalism, her current professional focus centers on advancing science-led biotechnology investments and healthcare policy initiatives across international markets.